The Market Reports

Index

1 Inactivated Influenza Vaccine Market Overview

1.1 Product Overview and Scope of Inactivated Influenza Vaccine

1.2 Inactivated Influenza Vaccine Segment by Type

1.2.1 Global Inactivated Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Inactivated Influenza Vaccine Segment by Application

1.3.1 Global Inactivated Influenza Vaccine Sales Comparison by Application: (2022-2028)

1.3.2 Children

1.3.3 Adolescence

1.3.4 Adults

1.3.5 Elderly

1.4 Global Inactivated Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Inactivated Influenza Vaccine Revenue 2017-2028

1.4.2 Global Inactivated Influenza Vaccine Sales 2017-2028

1.4.3 Inactivated Influenza Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028

2 Inactivated Influenza Vaccine Market Competition by Manufacturers

2.1 Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)

2.2 Global Inactivated Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Inactivated Influenza Vaccine Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Inactivated Influenza Vaccine Manufacturing Sites, Area Served, Product Type

2.5 Inactivated Influenza Vaccine Market Competitive Situation and Trends

2.5.1 Inactivated Influenza Vaccine Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Inactivated Influenza Vaccine Players Market Share by Revenue

2.5.3 Global Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inactivated Influenza Vaccine Retrospective Market Scenario by Region

3.1 Global Inactivated Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Inactivated Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Inactivated Influenza Vaccine Market Facts & Figures by Country

3.3.1 North America Inactivated Influenza Vaccine Sales by Country

3.3.2 North America Inactivated Influenza Vaccine Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Inactivated Influenza Vaccine Market Facts & Figures by Country

3.4.1 Europe Inactivated Influenza Vaccine Sales by Country

3.4.2 Europe Inactivated Influenza Vaccine Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Inactivated Influenza Vaccine Market Facts & Figures by Region

3.5.1 Asia Pacific Inactivated Influenza Vaccine Sales by Region

3.5.2 Asia Pacific Inactivated Influenza Vaccine Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Inactivated Influenza Vaccine Market Facts & Figures by Country

3.6.1 Latin America Inactivated Influenza Vaccine Sales by Country

3.6.2 Latin America Inactivated Influenza Vaccine Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.6.6 Colombia

3.7 Middle East and Africa Inactivated Influenza Vaccine Market Facts & Figures by Country

3.7.1 Middle East and Africa Inactivated Influenza Vaccine Sales by Country

3.7.2 Middle East and Africa Inactivated Influenza Vaccine Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Inactivated Influenza Vaccine Historic Market Analysis by Type

4.1 Global Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

4.2 Global Inactivated Influenza Vaccine Revenue Market Share by Type (2017-2022)

4.3 Global Inactivated Influenza Vaccine Price by Type (2017-2022)

5 Global Inactivated Influenza Vaccine Historic Market Analysis by Application

5.1 Global Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

5.2 Global Inactivated Influenza Vaccine Revenue Market Share by Application (2017-2022)

5.3 Global Inactivated Influenza Vaccine Price by Application (2017-2022)

6 Key Companies Profiled

6.1 CSL Limited

6.1.1 CSL Limited Corporation Information

6.1.2 CSL Limited Description and Business Overview

6.1.3 CSL Limited Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.1.4 CSL Limited Inactivated Influenza Vaccine Product Portfolio

6.1.5 CSL Limited Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.2.4 GSK Inactivated Influenza Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Sanofi Pasteur

6.3.1 Sanofi Pasteur Corporation Information

6.3.2 Sanofi Pasteur Description and Business Overview

6.3.3 Sanofi Pasteur Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Sanofi Pasteur Inactivated Influenza Vaccine Product Portfolio

6.3.5 Sanofi Pasteur Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Corporation Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Viatris Inactivated Influenza Vaccine Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 Hualan Biological

6.5.1 Hualan Biological Corporation Information

6.5.2 Hualan Biological Description and Business Overview

6.5.3 Hualan Biological Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Hualan Biological Inactivated Influenza Vaccine Product Portfolio

6.5.5 Hualan Biological Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.6.4 AstraZeneca Inactivated Influenza Vaccine Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Sinovac Biotech

6.6.1 Sinovac Biotech Corporation Information

6.6.2 Sinovac Biotech Description and Business Overview

6.6.3 Sinovac Biotech Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Sinovac Biotech Inactivated Influenza Vaccine Product Portfolio

6.7.5 Sinovac Biotech Recent Developments/Updates

6.8 Aleph Biomedical

6.8.1 Aleph Biomedical Corporation Information

6.8.2 Aleph Biomedical Description and Business Overview

6.8.3 Aleph Biomedical Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Aleph Biomedical Inactivated Influenza Vaccine Product Portfolio

6.8.5 Aleph Biomedical Recent Developments/Updates

6.9 Abbott Laboratories

6.9.1 Abbott Laboratories Corporation Information

6.9.2 Abbott Laboratories Description and Business Overview

6.9.3 Abbott Laboratories Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Abbott Laboratories Inactivated Influenza Vaccine Product Portfolio

6.9.5 Abbott Laboratories Recent Developments/Updates

6.10 Novartis International

6.10.1 Novartis International Corporation Information

6.10.2 Novartis International Description and Business Overview

6.10.3 Novartis International Inactivated Influenza Vaccine Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Novartis International Inactivated Influenza Vaccine Product Portfolio

6.10.5 Novartis International Recent Developments/Updates

7 Inactivated Influenza Vaccine Manufacturing Cost Analysis

7.1 Inactivated Influenza Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Inactivated Influenza Vaccine

7.4 Inactivated Influenza Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Inactivated Influenza Vaccine Distributors List

8.3 Inactivated Influenza Vaccine Customers

9 Inactivated Influenza Vaccine Market Dynamics

9.1 Inactivated Influenza Vaccine Industry Trends

9.2 Inactivated Influenza Vaccine Market Drivers

9.3 Inactivated Influenza Vaccine Market Challenges

9.4 Inactivated Influenza Vaccine Market Restraints

10 Global Market Forecast

10.1 Inactivated Influenza Vaccine Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Inactivated Influenza Vaccine by Type (2023-2028)

10.2 Inactivated Influenza Vaccine Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Inactivated Influenza Vaccine by Application (2023-2028)

10.3 Inactivated Influenza Vaccine Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Inactivated Influenza Vaccine by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Inactivated Influenza Vaccine by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

List of Tables

Table 1. Global Inactivated Influenza Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)

Table 2. Global Inactivated Influenza Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)

Table 3. Global Inactivated Influenza Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)

Table 4. Global Inactivated Influenza Vaccine Market Competitive Situation by Manufacturers in 2021

Table 5. Global Inactivated Influenza Vaccine Sales (K Units) of Key Manufacturers (2017-2022)

Table 6. Global Inactivated Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Inactivated Influenza Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)

Table 8. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers (2017-2022)

Table 9. Global Market Inactivated Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2017-2022)

Table 10. Manufacturers Inactivated Influenza Vaccine Manufacturing Sites and Area Served

Table 11. Manufacturers Inactivated Influenza Vaccine Product Type

Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 13. Global Inactivated Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inactivated Influenza Vaccine as of 2021)

Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 15. Global Inactivated Influenza Vaccine Sales by Region (2017-2022) & (K Units)

Table 16. Global Inactivated Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 17. Global Inactivated Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 18. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 19. North America Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 20. North America Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 21. North America Inactivated Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 22. North America Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 23. Europe Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 24. Europe Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 25. Europe Inactivated Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 26. Europe Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 27. Asia Pacific Inactivated Influenza Vaccine Sales by Region (2017-2022) & (K Units)

Table 28. Asia Pacific Inactivated Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 29. Asia Pacific Inactivated Influenza Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 30. Asia Pacific Inactivated Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 31. Latin America Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 32. Latin America Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 33. Latin America Inactivated Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 34. Latin America Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 35. Middle East and Africa Inactivated Influenza Vaccine Sales by Country (2017-2022) & (K Units)

Table 36. Middle East and Africa Inactivated Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 37. Middle East and Africa Inactivated Influenza Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 38. Middle East and Africa Inactivated Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 39. Global Inactivated Influenza Vaccine Sales by Type (2017-2022) & (K Units)

Table 40. Global Inactivated Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 41. Global Inactivated Influenza Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 42. Global Inactivated Influenza Vaccine Revenue Share by Type (2017-2022)

Table 43. Global Inactivated Influenza Vaccine Price by Type (2017-2022) & (US$/Unit)

Table 44. Global Inactivated Influenza Vaccine Sales (K Units) by Application (2017-2022)

Table 45. Global Inactivated Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 46. Global Inactivated Influenza Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 47. Global Inactivated Influenza Vaccine Revenue Share by Application (2017-2022)

Table 48. Global Inactivated Influenza Vaccine Price by Application (2017-2022) & (US$/Unit)

Table 49. CSL Limited Corporation Information

Table 50. CSL Limited Description and Business Overview

Table 51. CSL Limited Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 52. CSL Limited Inactivated Influenza Vaccine Product

Table 53. CSL Limited Recent Developments/Updates

Table 54. GSK Corporation Information

Table 55. GSK Description and Business Overview

Table 56. GSK Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 57. GSK Inactivated Influenza Vaccine Product

Table 58. GSK Recent Developments/Updates

Table 59. Sanofi Pasteur Corporation Information

Table 60. Sanofi Pasteur Description and Business Overview

Table 61. Sanofi Pasteur Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 62. Sanofi Pasteur Inactivated Influenza Vaccine Product

Table 63. Sanofi Pasteur Recent Developments/Updates

Table 64. Viatris Corporation Information

Table 65. Viatris Description and Business Overview

Table 66. Viatris Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 67. Viatris Inactivated Influenza Vaccine Product

Table 68. Viatris Recent Developments/Updates

Table 69. Hualan Biological Corporation Information

Table 70. Hualan Biological Description and Business Overview

Table 71. Hualan Biological Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 72. Hualan Biological Inactivated Influenza Vaccine Product

Table 73. Hualan Biological Recent Developments/Updates

Table 74. AstraZeneca Corporation Information

Table 75. AstraZeneca Description and Business Overview

Table 76. AstraZeneca Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 77. AstraZeneca Inactivated Influenza Vaccine Product

Table 78. AstraZeneca Recent Developments/Updates

Table 79. Sinovac Biotech Corporation Information

Table 80. Sinovac Biotech Description and Business Overview

Table 81. Sinovac Biotech Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 82. Sinovac Biotech Inactivated Influenza Vaccine Product

Table 83. Sinovac Biotech Recent Developments/Updates

Table 84. Aleph Biomedical Corporation Information

Table 85. Aleph Biomedical Description and Business Overview

Table 86. Aleph Biomedical Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 87. Aleph Biomedical Inactivated Influenza Vaccine Product

Table 88. Aleph Biomedical Recent Developments/Updates

Table 89. Abbott Laboratories Corporation Information

Table 90. Abbott Laboratories Description and Business Overview

Table 91. Abbott Laboratories Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 92. Abbott Laboratories Inactivated Influenza Vaccine Product

Table 93. Abbott Laboratories Recent Developments/Updates

Table 94. Novartis International Corporation Information

Table 95. Novartis International Description and Business Overview

Table 96. Novartis International Inactivated Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 97. Novartis International Inactivated Influenza Vaccine Product

Table 98. Novartis International Recent Developments/Updates

Table 99. Production Base and Market Concentration Rate of Raw Material

Table 100. Key Suppliers of Raw Materials

Table 101. Inactivated Influenza Vaccine Distributors List

Table 102. Inactivated Influenza Vaccine Customers List

Table 103. Inactivated Influenza Vaccine Market Trends

Table 104. Inactivated Influenza Vaccine Market Drivers

Table 105. Inactivated Influenza Vaccine Market Challenges

Table 106. Inactivated Influenza Vaccine Market Restraints

Table 107. Global Inactivated Influenza Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 108. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 109. Global Inactivated Influenza Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)

Table 110. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 111. Global Inactivated Influenza Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 112. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 113. Global Inactivated Influenza Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)

Table 114. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 115. Global Inactivated Influenza Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 116. Global Inactivated Influenza Vaccine Sales Market Share Forecast by Region (2023-2028)

Table 117. Global Inactivated Influenza Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)

Table 118. Global Inactivated Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Inactivated Influenza Vaccine

Figure 2. Global Inactivated Influenza Vaccine Market Share by Type in 2021 & 2028

Figure 3. Trivalent Influenza Vaccine Product Picture

Figure 4. Quadrivalent Influenza Vaccine Product Picture

Figure 5. Global Inactivated Influenza Vaccine Market Share by Application in 2021 & 2028

Figure 6. Children

Figure 7. Adolescence

Figure 8. Adults

Figure 9. Elderly

Figure 10. Global Inactivated Influenza Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Inactivated Influenza Vaccine Market Size (2017-2028) & (US$ Million)

Figure 12. Global Inactivated Influenza Vaccine Sales (2017-2028) & (K Units)

Figure 13. Inactivated Influenza Vaccine Sales Share by Manufacturers in 2021

Figure 14. Global Inactivated Influenza Vaccine Revenue Share by Manufacturers in 2021

Figure 15. The Global 5 and 10 Largest Inactivated Influenza Vaccine Players: Market Share by Revenue in 2021

Figure 16. Inactivated Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 17. Global Inactivated Influenza Vaccine Sales Market Share by Region (2017-2022)

Figure 18. Global Inactivated Influenza Vaccine Sales Market Share by Region in 2021

Figure 19. Global Inactivated Influenza Vaccine Revenue Market Share by Region (2017-2022)

Figure 20. Global Inactivated Influenza Vaccine Revenue Market Share by Region in 2021

Figure 21. United States Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 22. Canada Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 23. Germany Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 24. France Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 25. U.K. Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 26. Italy Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 27. Russia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 28. China Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 29. Japan Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 30. South Korea Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 31. India Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 32. Australia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 33. China Taiwan Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 34. Indonesia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 35. Thailand Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 36. Malaysia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 37. Mexico Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 38. Brazil Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 39. Argentina Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 40. Colombia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 41. Turkey Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 42. Saudi Arabia Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 43. UAE Inactivated Influenza Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)

Figure 44. Sales Market Share of Inactivated Influenza Vaccine by Type (2017-2022)

Figure 45. Manufacturing Cost Structure of Inactivated Influenza Vaccine

Figure 46. Manufacturing Process Analysis of Inactivated Influenza Vaccine

Figure 47. Inactivated Influenza Vaccine Industrial Chain Analysis

Figure 48. Channels of Distribution

Figure 49. Distributors Profiles

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed